Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 1.3B | 1.0B | 2.0B | 1.4B |
Cost of revenue | 623.3M | 483.6M | 1.1B | 633.7M |
Gross profit | 633.0M | 519.2M | 908.3M | 801.8M |
Operating expense | ||||
Research & development | 244.3M | 217.8M | 252.3M | 279.6M |
Selling general and admin | 48.6M | 291.7M | -245.3M | 730.7M |
Other operating expenses | 5.3M | 12.7M | 29.3M | 12.1M |
Operating income | 37.7M | 11.3M | 193.1M | 103.7M |
Non operating interest income | ||||
Income | 11.5M | 5.1M | 19.1M | 6.1M |
Expense | 20.4M | 18.1M | 24.7M | 28.6M |
Other income expense | — | — | — | — |
Pretax income | 58.8M | 39.4M | -3.7B | 67.6M |
Tax provision | -2.6M | 16.2M | 67.7M | -22.0M |
Net income | 61.4M | 23.2M | -3.7B | 89.6M |
Basic EPS | — | 0.0 | — | — |
Diluted EPS | — | 0.0 | — | — |
Basic average shares | — | 1.8B | — | — |
Diluted average shares | — | 1.8B | — | — |
EBITDA | 99.0M | 30.8M | -3.5B | 123.9M |
Net income from continuing op. | — | — | — | — |
Minority interests | 5.1M | 3.9M | -1.3M | -514.6K |
Preferred stock dividends | 0 | 0 | 0 | 0 |